Smeekens Johanna M, Kesselring Janelle R, Frizzell Hannah, Bagley Kenneth C, Kulis Michael D
Department of Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, NC, United States.
UNC Food Allergy Initiative, School of Medicine, University of North Carolina, Chapel Hill, NC, United States.
Front Allergy. 2022 Sep 19;3:969337. doi: 10.3389/falgy.2022.969337. eCollection 2022.
Shellfish and tree nut allergies are among the most prevalent food allergies, now affecting 2%-3% and 1% of the US population, respectively. Currently, there are no approved therapies for shellfish or tree nut allergies, with strict avoidance being the standard of care. However, oral immunotherapy for peanut allergy and subcutaneous immunotherapy for environmental allergens are efficacious and lead to the production of allergen-specific IgG, which causes suppression of allergen effector cell degranulation. Since allergen-specific IgG is a desired response to alleviate IgE-mediated allergies, we tested transcutaneously-delivered DNA vaccines targeting shellfish and tree nut allergens for their ability to induce antigen-specific IgG, which would have therapeutic potential for food allergies.
We assessed Gene Gun-delivered DNA vaccines targeting either crustacean shellfish or walnut/pecan allergens, with or without IL-12, in naïve mice. Three strains of mice, BALB/cJ, C3H/HeJ and CC027/GeniUnc, were evaluated for IgG production following vaccination. Vaccines were administered twice Gene Gun, three weeks apart and then blood was collected three weeks following the final vaccination.
Vaccination with shellfish allergen DNA led to increased shrimp-specific IgG in all three strains, with the highest production in C3H/HeJ from the vaccine alone, whereas the vaccine with IL-12 led to the highest IgG production in BALB/cJ and CC027/GeniUnc mice. Similar IgG production was also induced against lobster and crab allergens. For walnut/pecan vaccines, BALB/cJ and C3H/HeJ mice produced significantly higher walnut- and pecan-specific IgG with the vaccine alone compared to the vaccine with IL-12, while the CC027 mice made significantly higher IgG with the addition of IL-12. Notably, intramuscular administration of the vaccines did not lead to increased antigen-specific IgG production, indicating that Gene Gun administration is a superior delivery modality.
Overall, these data demonstrate the utility of DNA vaccines against two lifelong food allergies, shellfish and tree nuts, suggesting their potential as a food allergy therapy in the future.
贝类和坚果过敏是最常见的食物过敏类型,目前分别影响着2% - 3%的美国人口和1%的美国人口。目前,尚无获批用于治疗贝类或坚果过敏的疗法,严格避免接触是标准治疗方法。然而,花生过敏的口服免疫疗法和环境过敏原的皮下免疫疗法是有效的,可导致产生过敏原特异性IgG,从而抑制过敏原效应细胞脱颗粒。由于过敏原特异性IgG是缓解IgE介导的过敏反应的理想反应,我们测试了经皮递送的针对贝类和坚果过敏原的DNA疫苗诱导抗原特异性IgG的能力,这可能对食物过敏具有治疗潜力。
我们在未接触过抗原的小鼠中评估了基因枪递送的针对甲壳类贝类或核桃/山核桃过敏原的DNA疫苗,有无添加IL - 12。评估了三种品系的小鼠,即BALB/cJ、C3H/HeJ和CC027/GeniUnc,接种疫苗后IgG的产生情况。疫苗通过基因枪接种两次,间隔三周,最后一次接种三周后采集血液。
接种贝类过敏原DNA疫苗后,所有三个品系小鼠体内虾特异性IgG均增加,单独接种疫苗时C3H/HeJ品系产生的IgG最高,而添加IL - 12的疫苗在BALB/cJ和CC027/GeniUnc小鼠中诱导产生的IgG最高。针对龙虾和蟹过敏原也诱导产生了类似的IgG。对于核桃/山核桃疫苗,与添加IL - 12的疫苗相比,单独接种疫苗时BALB/cJ和C3H/HeJ小鼠产生的核桃和山核桃特异性IgG显著更高,而CC027品系小鼠在添加IL - 12后产生的IgG显著更高。值得注意的是,肌肉注射疫苗并未导致抗原特异性IgG产生增加,这表明基因枪接种是一种更优的递送方式。
总体而言,这些数据证明了DNA疫苗对两种终身性食物过敏(贝类和坚果)的有效性,表明其未来作为食物过敏治疗方法的潜力。